The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.
Estrogen biology: New insights into GPER function and clinical opportunities
Open accessAbstract
Estrogens play an important role in the regulation of normal physiology, aging and many disease states. Although the nuclear estrogen receptors have classically been described to function as ligand-activated transcription factors mediating genomic effects in hormonally regulated tissues, more recent studies reveal that estrogens also mediate rapid signaling events traditionally associated with G protein-coupled receptors. The G protein-coupled estrogen receptor GPER (formerly GPR30) has now become recognized as a major mediator of estrogen’s rapid cellular effects throughout the body. With the discovery of selective synthetic ligands for GPER, both agonists and antagonists, as well as the use of GPER knockout mice, significant advances have been made in our understanding of GPER function at the cellular, tissue and organismal levels. In many instances, the protective/beneficial effects of estrogen are mimicked by selective GPER agonism and are absent or reduced in GPER knockout mice, suggesting an essential or at least parallel role for GPER in the actions of estrogen. In this review, we will discuss recent advances and our current understanding of the role of GPER and certain drugs such as SERMs and SERDs in physiology and disease. We will also highlight novel opportunities for clinical development towards GPER-targeted therapeutics, for molecular imaging, as well as for theranostic approaches and personalized medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Vivacqua, A., Bonofiglio, D., Albanito, L., Madeo, A., Rago, V., Carpino, A., Musti, A. M., Picard, D., Andò, S., & Maggiolini, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026344 · Cited by 280
RetractedAlbanito, L., Lappano, R., Madeo, A., Chimento, A., Prossnitz, E. R., Cappello, A. R., Dolce, V., Abonante, S., Pezzi, V., & Maggiolini, M. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11297 · Cited by 108
Self-citationRetractedCloning of a novel receptor expressed in rat prostate and ovary.
Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., & Gustafsson, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5925 · Cited by 4,788
Macrophages in atherosclerosis: a dynamic balance
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559
A transmembrane intracellular estrogen receptor mediates rapid cell signaling
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005) · Science · doi:10.1126/science.1106943 · Cited by 2,302
Self-citationDifferential oestrogen receptor binding is associated with clinical outcome in breast cancer
Ross-Innes, C. S., Stark, R., Teschendorff, A. E., Holmes, K. A., Ali, H. R., Dunning, M. J., Brown, G. D., Gojis, O., Ellis, I. O., Green, A. R., et al. (2012) · Nature · doi:10.1038/nature10730 · Cited by 2,173
Guide to receptors and channels (GRAC), 5th edition
Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947
Estrogen receptors: how do they signal and what are their targets
Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., Tujague, M., Ström, A., Treuter, E., Warner, M., et al. (2007) · Physiological Reviews · doi:10.1152/physrev.00026.2006 · Cited by 1,857
Molecular signatures of G-protein-coupled receptors
Venkatakrishnan, A. J., Deupi, X., Lebon, G., Tate, C. G., Schertler, G. F., & Babu, M. M. (2013) · Nature · doi:10.1038/nature11896 · Cited by 1,497
Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors
Daub, H., Ulrich Weiss, F., Wallasch, C., & Ullrich, A. (1996) · Nature · doi:10.1038/379557a0 · Cited by 1,476
Identity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer Cells
Thomas, P., Pang, Y., Filardo, E. J., & Dong, J. (2005) · Endocrinology · doi:10.1210/en.2004-1064 · Cited by 1,407
Differential Oestrogen Receptor Binding is Associated with Clinical Outcome in Breast Cancer
Stark, R. (2012) · Lecture Notes in Computer Science · doi:10.1007/978-3-642-29627-7_30 · Cited by 1,403
Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells
King, W. J., & Greene, G. L. (1984) · Nature · doi:10.1038/307745a0 · Cited by 1,400
Filardo, E. J. (2000) · Molecular Endocrinology · doi:10.1210/me.14.10.1649 · Cited by 1,383
Björnström, L., & Sjöberg, M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0486 · Cited by 1,362
Sequence and Expression of Human Estrogen Receptor Complementary DNA
Greene, G. L., Gilna, P., Waterfield, M., Baker, A., Hort, Y., & Shine, J. (1986) · Science · doi:10.1126/science.3753802 · Cited by 1,311
Multiple Actions of Steroid Hormones—A Focus on Rapid, Nongenomic Effects
Falkenstein, E., Tillmann, H.-C., Christ, M., Feuring, M., & Wehling, M. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01468-6 · Cited by 991
The G-protein-coupled estrogen receptor GPER in health and disease
Prossnitz, E. R., & Barton, M. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.122 · Cited by 925 · cited 11×
“through ERE-independent mechanisms (Lindsey and Chappell, 2011; Prossnitz and Barton, 2011; Filardo and Thomas, 2012; Han et al., 2013).”
BackgroundInfluentialSelf-citationFilardo, E. J., Quinn, J. A., Frackelton, A. R., & Bland, K. I. (2002) · Molecular Endocrinology · doi:10.1210/me.16.1.70 · Cited by 904
Virtual and biomolecular screening converge on a selective agonist for GPR30
Bologa, C. G., Revankar, C. M., Young, S. M., Edwards, B. S., Arterburn, J. B., Kiselyov, A. S., Parker, M. A., Tkachenko, S. E., Savchuck, N. P., Sklar, L. A., et al. (2006) · Nature Chemical Biology · doi:10.1038/nchembio775 · Cited by 818
Self-citationThomas, P., & Dong, J. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.017 · Cited by 603
Carmeci, C., Thompson, D. A., Ring, H. Z., Francke, U., & Weigel, R. J. (1997) · Genomics · doi:10.1006/geno.1997.4972 · Cited by 591
Estrogen Signaling through the Transmembrane G Protein–Coupled Receptor GPR30
Prossnitz, E. R., Arterburn, J. B., Smith, H. O., Oprea, T. I., Sklar, L. A., & Hathaway, H. J. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100518 · Cited by 590
Self-citationVitamin D and Cardiovascular Disease
Norman, P. E., & Powell, J. T. (2014) · Circulation Research · doi:10.1161/circresaha.113.301241 · Cited by 576
Enabling personalized cancer medicine through analysis of gene-expression patterns
van 't Veer, L. J., & Bernards, R. (2008) · Nature · doi:10.1038/nature06915 · Cited by 554
Estrogen: A master regulator of bioenergetic systems in the brain and body
Rettberg, J. R., Yao, J., & Brinton, R. D. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.08.001 · Cited by 534
In vivo effects of a GPR30 antagonist
Dennis, M. K., Burai, R., Ramesh, C., Petrie, W. K., Alcon, S. N., Nayak, T. K., Bologa, C. G., Leitao, A., Brailoiu, E., Deliu, E., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.168 · Cited by 532
Self-citationREGULATION OF SIGNAL TRANSDUCTION PATHWAYS BY ESTROGEN AND PROGESTERONE
Edwards, D. P. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.040403.120151 · Cited by 502
Estrogen and the cardiovascular system
Knowlton, A. A., & Lee, A. R. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.03.007 · Cited by 489
Qiu, J., Bosch, M. A., Tobias, S. C., Grandy, D. K., Scanlan, T. S., Rønnekleiv, O. K., & Kelly, M. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-29-09529.2003 · Cited by 457
Dripps, D. J., Brandhuber, B. J., Thompson, R. C., & Eisenberg, S. P. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99230-6 · Cited by 452
Maggiolini, M., Vivacqua, A., Fasanella, G., Recchia, A. G., Sisci, D., Pezzi, V., Montanaro, D., Musti, A. M., Picard, D., & Andò, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403588200 · Cited by 448
Molecular mechanisms underlying the activation of eNOS
Fleming, I. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0767-7 · Cited by 437
Mårtensson, U. E. A., Salehi, S. A., Windahl, S., Gomez, M. F., Swärd, K., Daszkiewicz-Nilsson, J., Wendt, A., Andersson, N., Hellstrand, P., Grände, P.-O., et al. (2009) · Endocrinology · doi:10.1210/en.2008-0623 · Cited by 413
Adenosine 3',5'-monophosphate in rat uterus: acute elevation by estrogen.
Szego, C. M., & Davis, J. S. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.58.4.1711 · Cited by 404
Albanito, L., Madeo, A., Lappano, R., Vivacqua, A., Rago, V., Carpino, A., Oprea, T. I., Prossnitz, E. R., Musti, A. M., Andò, S., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2909 · Cited by 399
Self-citationTHE LUTEINIZING HORMONE RECEPTOR
Dufau, M. L. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.461 · Cited by 398
Wang, Z., Zhang, X., Shen, P., Loggie, B. W., Chang, Y., & Deuel, T. F. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.226 · Cited by 392
Wang, Z., Zhang, X., Shen, P., Loggie, B. W., Chang, Y., & Deuel, T. F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603339103 · Cited by 380
Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity
Haas, E., Bhattacharya, I., Brailoiu, E., Damjanović, M., Brailoiu, G. C., Gao, X., Mueller-Guerre, L., Marjon, N. A., Gut, A., Minotti, R., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.190892 · Cited by 373
Self-citationFilardo, E. J., & Thomas, P. (2012) · Endocrinology · doi:10.1210/en.2012-1061 · Cited by 366
Plasma membrane estrogen receptors
Levin, E. R. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.06.009 · Cited by 365
Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors
McCurley, A., Pires, P. W., Bender, S. B., Aronovitz, M., Zhao, M. J., Metzger, D., Chambon, P., Hill, M. A., Dorrance, A. M., Mendelsohn, M. E., et al. (2012) · Nature Medicine · doi:10.1038/nm.2891 · Cited by 347
Mechanisms of estrogen signaling and gene expression via GPR30
Prossnitz, E. R., & Maggiolini, M. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.03.026 · Cited by 346
Self-citationVivacqua, A., Bonofiglio, D., Recchia, A. G., Musti, A. M., Picard, D., Andò, S., & Maggiolini, M. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0280 · Cited by 341
Discovery of Three Novel G-Protein-Coupled Receptor Genes
O'Dowd, B. F., Nguyen, T., Marchese, A., Cheng, R., Lynch, K. R., Heng, H. H. Q., Kolakowski, L. F., & George, S. R. (1998) · Genomics · doi:10.1006/geno.1998.5095 · Cited by 334
Meyer, M. R., Clegg, D. J., Prossnitz, E. R., & Barton, M. (2011) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02237.x · Cited by 332
Self-citationEstrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF
Pandey, D. P., Lappano, R., Albanito, L., Madeo, A., Maggiolini, M., & Picard, D. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.304 · Cited by 327
Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity
Dennis, M. K., Field, A. S., Burai, R., Ramesh, C., Petrie, W. K., Bologa, C. G., Oprea, T. I., Yamaguchi, Y., Hayashi, S.-I., Sklar, L. A., et al. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.07.002 · Cited by 311
Self-citationCloning of the human oestrogen receptor cDNA
Green, S., Walter, P., Greene, G., Krust, A., Goffin, C., Jensen, E., Scrace, G., Waterfield, M., & Chambon, P. (1986) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(86)90035-x · Cited by 302
Pupo, M., Pisano, A., Lappano, R., Santolla, M. F., De Francesco, E. M., Abonante, S., Rosano, C., & Maggiolini, M. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104526 · Cited by 296
Endometrial cell calcium and oestrogen action
PIETRAS, R. J., & SZEGO, C. M. (1975) · Nature · doi:10.1038/253357a0 · Cited by 266
Otto, C., Rohde-Schulz, B., Schwarz, G., Fuchs, I., Klewer, M., Brittain, D., Langer, G., Bader, B., Prelle, K., Nubbemeyer, R., et al. (2008) · Endocrinology · doi:10.1210/en.2008-0269 · Cited by 254
Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats
Deschamps, A. M., & Murphy, E. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00283.2009 · Cited by 252
Chambliss, K. L., Wu, Q., Oltmann, S., Konaniah, E. S., Umetani, M., Korach, K. S., Thomas, G. D., Mineo, C., Yuhanna, I. S., Kim, S. H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38291 · Cited by 250
Gros, R., Ding, Q., Sklar, L. A., Prossnitz, E. E., Arterburn, J. B., Chorazyczewski, J., & Feldman, R. D. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.161653 · Cited by 243
Self-citationInvolvement of Estrogen Receptor Variant ER-α36, Not GPR30, in Nongenomic Estrogen Signaling
Kang, L., Zhang, X., Xie, Y., Tu, Y., Wang, D., Liu, Z., & Wang, Z.-Y. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0317 · Cited by 241
Pharmacogenetics and the concept of individualized medicine
Shastry, B. S. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500338 · Cited by 236
The diversity of sex steroid action: regulation of metabolism by estrogen signaling
Faulds, M. H., Zhao, C., Dahlman-Wright, K., & Gustafsson, J.-Å. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0044 · Cited by 230
Endothelium independent relaxation of human coronary arteries by 17 -oestradiol in vitro
Mugge, A., Riedel, M., Barton, M., Kuhn, M., & Lichtlen, P. R. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.11.1939 · Cited by 228
Self-citationSukocheva, O., Wadham, C., Holmes, A., Albanese, N., Verrier, E., Feng, F., Bernal, A., Derian, C. K., Ullrich, A., Vadas, M. A., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200506033 · Cited by 228
De Francesco, E. M., Lappano, R., Santolla, M. F., Marsico, S., Caruso, A., & Maggiolini, M. (2013) · Breast Cancer Research · doi:10.1186/bcr3458 · Cited by 227
Owman, C., Blay, P., Nilsson, C., & Lolait, S. J. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1654 · Cited by 224
Estrogen Induces Expression of c-fos and c-myc Protooncogenes in Rat Uterus
Weisz, A., & Bresciani, F. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-9-816 · Cited by 220
GPR30: a novel indicator of poor survival for endometrial carcinoma
Smith, H. O., Leslie, K. K., Singh, M., Qualls, C. R., Revankar, C. M., Joste, N. E., & Prossnitz, E. R. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.01.004 · Cited by 214
Self-citationLafferty, A. R., Torpy, D. J., Stowasser, M., Taymans, S. E., Lin, J. P., Huggard, P., Gordon, R. D., & Stratakis, C. A. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.11.831 · Cited by 212
Post-Translational Modifications of Nuclear Receptors and Human Disease
Anbalagan, M., Huderson, B., Murphy, L., & Rowan, B. G. (2012) · Nuclear Receptor Signaling · doi:10.1621/nrs.10001 · Cited by 211
Bisphenol A induces a rapid activation of Erk1/2 through GPR30 in human breast cancer cells
Dong, S., Terasaka, S., & Kiyama, R. (2011) · Environmental Pollution · doi:10.1016/j.envpol.2010.09.004 · Cited by 211
Sharma, G., Hu, C., Brigman, J. L., Zhu, G., Hathaway, H. J., & Prossnitz, E. R. (2013) · Endocrinology · doi:10.1210/en.2013-1357 · Cited by 210
Self-citationTakada, Y., Kato, C., Kondo, S., Korenaga, R., & Ando, J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7734 · Cited by 210
Estrogen effects in allergy and asthma
Bonds, R. S., & Midoro-Horiuti, T. (2013) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e32835a6dd6 · Cited by 208
GPR30 predicts poor survival for ovarian cancer
Smith, H. O., Arias-Pulido, H., Kuo, D. Y., Howard, T., Qualls, C. R., Lee, S.-J., Verschraegen, C. F., Hathaway, H. J., Joste, N. E., & Prossnitz, E. R. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.05.015 · Cited by 206
Self-citationGPR30 Contributes to Estrogen-Induced Thymic Atrophy
Chunhe, C., Dehghani, B., Magrisso, I. J., Rick, E. A., Bonhomme, E., Cody, D. B., Elenich, L. A., Subramanian, S., Murphy, S. J., Kelly, M. J., et al. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0359 · Cited by 205
Estrogen Receptor-Mediated Rapid Signaling
Moriarty, K., Kim, K. H., & Bender, J. R. (2006) · Endocrinology · doi:10.1210/en.2006-0729 · Cited by 205
Personalized medicine: new genomics, old lessons
Offit, K. (2011) · Human Genetics · doi:10.1007/s00439-011-1028-3 · Cited by 203
Bopassa, J. C., Eghbali, M., Toro, L., & Stefani, E. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00588.2009 · Cited by 197
Targeting the Inflammatory Response in Healing Myocardial Infarcts
Frangogiannis, N. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777585086 · Cited by 190
Expression Pattern of G Protein-Coupled Receptor 30 in LacZ Reporter Mice
Isensee, J., Meoli, L., Zazzu, V., Nabzdyk, C., Witt, H., Soewarto, D., Effertz, K., Fuchs, H., Gailus-Durner, V., Busch, D., et al. (2009) · Endocrinology · doi:10.1210/en.2008-1488 · Cited by 189
Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis
Blasko, E., Haskell, C. A., Leung, S., Gualtieri, G., Halks-Miller, M., Mahmoudi, M., Dennis, M. K., Prossnitz, E. R., Karpus, W. J., & Horuk, R. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.06.023 · Cited by 181
Self-citationTiano, J. P., Delghingaro-Augusto, V., Le May, C., Liu, S., Kaw, M. K., Khuder, S. S., Latour, M. G., Bhatt, S. A., Korach, K. S., Najjar, S. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44564 · Cited by 180
Lindsey, S. H., Cohen, J. A., Brosnihan, K. B., Gallagher, P. E., & Chappell, M. C. (2009) · Endocrinology · doi:10.1210/en.2008-1664 · Cited by 179
Madeo, A., & Maggiolini, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0408 · Cited by 179
Gender Differences of Cardiovascular Disease: New Perspectives for Estrogen Receptor Signaling
Meyer, M. R., Haas, E., & Barton, M. (2006) · Hypertension · doi:10.1161/01.hyp.0000223064.62762.0b · Cited by 178
Self-citationMechanisms of Estrogen Effects on the Endothelium: An Overview
Chakrabarti, S., Morton, J. S., & Davidge, S. T. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.08.006 · Cited by 174
Gonadal steroids and humoral immunity
Sakiani, S., Olsen, N. J., & Kovacs, W. J. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.206 · Cited by 171
Why are sex and gender important to basic physiology and translational and individualized medicine?
Miller, V. M. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00994.2013 · Cited by 168
The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function
Meyer, M. R., Prossnitz, E. R., & Barton, M. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.06.003 · Cited by 168
Self-citationG Protein-Coupled Estrogen Receptor-Selective Ligands Modulate Endometrial Tumor Growth
Petrie, W. K., Dennis, M. K., Hu, C., Dai, D., Arterburn, J. B., Smith, H. O., Hathaway, H. J., & Prossnitz, E. R. (2013) · Obstetrics and Gynecology International · doi:10.1155/2013/472720 · Cited by 166
Self-citationKanda, N., & Watanabe, S. (2003) · Journal of Investigative Dermatology · doi:10.1111/j.1523-1747.2003.12617.x · Cited by 166
Sharma, G., & Prossnitz, E. R. (2011) · Endocrinology · doi:10.1210/en.2011-0091 · Cited by 166
Self-citationAldosterone mediates its rapid effects in vascular endothelial cells through GPER activation
Gros, R., Ding, Q., Liu, B., Chorazyczewski, J., & Feldman, R. D. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00203.2012 · Cited by 166
Haas, E., Meyer, M. R., Schurr, U., Bhattacharya, I., Minotti, R., Nguyen, H. H., Heigl, A., Lachat, M., Genoni, M., & Barton, M. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.089995 · Cited by 165
Self-citation17β-Estradiol Stimulates the Growth of Human Keratinocytes by Inducing Cyclin D2 Expression
Kanda, N., & Watanabe, S. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.12645.x · Cited by 159
Lin, B. C., Suzawa, M., Blind, R. D., Tobias, S. C., Bulun, S. E., Scanlan, T. S., & Ingraham, H. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1622 · Cited by 157
Wang, C., Dehghani, B., Li, Y., Kaler, L. J., Proctor, T., Vandenbark, A. A., & Offner, H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803205 · Cited by 156
Synthetic Estrogen Derivatives Demonstrate the Functionality of Intracellular GPR30
Revankar, C. M., Mitchell, H. D., Field, A. S., Burai, R., Corona, C. R., Ramesh, C., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2007) · ACS Chemical Biology · doi:10.1021/cb700072n · Cited by 155
Self-citationEstrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo
Hutchens, M. P., Fujiyoshi, T., Komers, R., Herson, P. S., & Anderson, S. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00354.2011 · Cited by 148
Cholesterol and atherosclerosis
Barton, M. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283613a94 · Cited by 140
Self-citationGPR30: a novel therapeutic target in estrogen-related disease
Prossnitz, E. R., Sklar, L. A., Oprea, T. I., & Arterburn, J. B. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.01.001 · Cited by 137
Self-citationEstriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells
Lappano, R., Rosano, C., Marco, P. D., Francesco, E. M. D., Pezzi, V., & Maggiolini, M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.02.006 · Cited by 137
Pruthi, D., McCurley, A., Aronovitz, M. A., Galayda, C., Karumanchi, S. A., & Jaffe, I. Z. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302854 · Cited by 137
O’Brien, J. E., Peterson, T. J., Tong, M. H., Lee, E. J., Pfaff, L. E., Hewitt, S. C., Korach, K. S., Weiss, J., & Jameson, J. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601522200 · Cited by 136
Golias, C., Tsoutsi, E., Matziridis, A., Makridis, P., Batistatou, A. K., & Charalabopoulos, A. (2007) · PubMed · Cited by 131
Shifting emphasis from pharmacogenomics to theragnostics
Özdemir, V., Williams–Jones, B., Glatt, S. J., Tsuang, M. T., Lohr, J. B., & Reist, C. (2006) · Nature Biotechnology · doi:10.1038/nbt0806-942 · Cited by 130
Vascular Smooth Muscle Cells as Target for Estrogen
Orimo, A., Inoue, S., Ikegami, A., Hosoi, T., Akishita, M., Ouchi, Y., Muramatsu, M., & Orimo, H. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2106 · Cited by 129
Cheng, S., Graeber, C. T., Quinn, J. A., & Filardo, E. J. (2011) · Steroids · doi:10.1016/j.steroids.2011.02.018 · Cited by 129
Pernis, A. B. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328277ef2a · Cited by 129
Non-genomic regulation of vascular cell function and growth by estrogen
Meyer, M. R., Haas, E., Prossnitz, E. R., & Barton, M. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.03.009 · Cited by 129
Self-citationEstradiol and G1 Reduce Infarct Size and Improve Immunosuppression after Experimental Stroke
Zhang, B., Subramanian, S., Dziennis, S., Jia, J., Uchida, M., Akiyoshi, K., Migliati, E., Lewis, A. D., Vandenbark, A. A., Offner, H., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902339 · Cited by 126
Wang, H., Jessup, J. A., Lin, M. S., Chagas, C., Lindsey, S. H., & Groban, L. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs090 · Cited by 124
Cheng, S., Quinn, J. A., Graeber, C. T., & Filardo, E. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.224071 · Cited by 122
Meyer, M. R., Baretella, O., Prossnitz, E. R., & Barton, M. (2010) · Pharmacology · doi:10.1159/000315497 · Cited by 121
Self-citationMembrane-initiated actions of estrogen on the endothelium
Kim, K. H., & Bender, J. R. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.03.025 · Cited by 119
Position paper: The membrane estrogen receptor GPER – Clues and questions
Barton, M. (2012) · Steroids · doi:10.1016/j.steroids.2012.04.001 · Cited by 115
Self-citationQiu, J., Rönnekleiv, O., & KELLY, M. (2008) · Steroids · doi:10.1016/j.steroids.2007.11.008 · Cited by 114
Estradiol-mediated ERK phosphorylation and apoptosis in vascular smooth muscle cells requires GPR 30
Ding, Q., Gros, R., Limbird, L. E., Chorazyczewski, J., & Feldman, R. D. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00185.2009 · Cited by 112
Non-nuclear Estrogen Receptor Signaling in the Endothelium
Wu, Q., Chambliss, K. L., Umetani, M., Mineo, C., & Shaul, P. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.191791 · Cited by 112
Lindsey, S. H., Yamaleyeva, L. M., Brosnihan, K. B., Gallagher, P. E., & Chappell, M. C. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.175174 · Cited by 112
Lindsey, S. H., Liu, L., & Chappell, M. C. (2013) · Steroids · doi:10.1016/j.steroids.2013.10.017 · Cited by 109
G-Protein Coupled Receptor 30 (GPR30): A Novel Regulator of Endothelial Inflammation
Chakrabarti, S., & Davidge, S. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052357 · Cited by 108
Roles of transactivating functions 1 and 2 of estrogen receptor-α in bone
Börjesson, A., Windahl, S. H., Lagerquist, M. K., Engdahl, C., Frenkel, B., Movérare‐Skrtic, S., Sjögren, K., Kindblom, J. M., Stubelius, A., Islander, U., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100454108 · Cited by 106
Gao, F., Ma, X., Ostmann, A. B., & Das, S. K. (2011) · Endocrinology · doi:10.1210/en.2010-1368 · Cited by 106
A novel putative G‐protein‐coupled receptor expressed in lung, heart and lymphoid tissue
Kvingedal, A. M., & Smeland, E. B. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00278-0 · Cited by 106
Brunsing, R. L., & Prossnitz, E. R. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03471.x · Cited by 105
Self-citationFord, J. J., Hajibeigi, A., Long, M., Hahner, L., Gore, C., Hsieh, J.-T., Clegg, D. J., Zerwekh, J. E., & Öz, O. K. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.209 · Cited by 105
Cheng, S., Dong, J., Pang, Y., LaRocca, J. L., Hixon, M. L., Thomas, P., & Filardo, E. J. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.11.005 · Cited by 104
Broughton, B. R. S., Brait, V. H., Kim, H. A., Lee, S., Chu, H. X., Gardiner-Mann, C. V., Guida, E., Evans, M. A., Miller, A. A., Arumugam, T. V., et al. (2014) · Stroke · doi:10.1161/strokeaha.113.001499 · Cited by 103
Yu, X., Ma, H., Barman, S. A., Liu, A. T., Sellers, M., Stallone, J. N., Prossnitz, E. R., White, R. E., & Han, G. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00037.2011 · Cited by 102
Self-citationCloning of a Novel Member of the G Protein-Coupled Receptor Family Related to Peptide Receptors
Feng, Y., & Gregor, P. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6161 · Cited by 102
GPR30/GPER-1 mediates rapid decreases in TLR4 expression on murine macrophages
Rettew, J. A., McCall, S. H., & Marriott, I. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.07.017 · Cited by 99
Kanda, N., & Watanabe, S. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12487.x · Cited by 97
MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells
Lappano, R., Santolla, M. F., Pupo, M., Sinicropi, M. S., Caruso, A., Rosano, C., & Maggiolini, M. (2012) · Breast Cancer Research · doi:10.1186/bcr3096 · Cited by 97
Chimento, A., Casaburi, I., Rosano, C., Avena, P., Luca, A. D., Campana, C., Martire, E., Santolla, M. F., Maggiolini, M., Pezzi, V., et al. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300323 · Cited by 96
Vivacqua, A., Romeo, E., Marco, P. D., Francesco, E. M. D., Abonante, S., & Maggiolini, M. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1901-8 · Cited by 96
Wang, C., Prossnitz, E. R., & Roy, S. K. (2008) · Endocrinology · doi:10.1210/en.2008-0441 · Cited by 95
Self-citationPeyton, C., & Thomas, P. (2011) · Biology of Reproduction · doi:10.1095/biolreprod.110.088765 · Cited by 94
Cross-talk between GPER and growth factor signaling
Lappano, R., Marco, P. D., Francesco, E. M. D., Chimento, A., Pezzi, V., & Maggiolini, M. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.03.005 · Cited by 93
Bartella, V., Marco, P. D., Malaguarnera, R., Belfiore, A., & Maggiolini, M. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.03.012 · Cited by 93
Liu, X., Zhu, P., Sham, K. W. Y., Yuen, J. M. L., Xie, C., Zhang, Y., Liu, Y., Li, S., Huang, X., Cheng, C. H. K., et al. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.108.070250 · Cited by 92
Quinn, J. A., Graeber, C. T., Frackelton, A. R., Kim, M., Schwarzbauer, J. E., & Filardo, E. J. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0262 · Cited by 91
Kajta, M., Rzemieniec, J., Litwa, E., Lasoń, W., Lenartowicz, M., Krzeptowski, W., & Wójtowicz, A. K. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.02.005 · Cited by 91
Bisphenol A promotes testicular seminoma cell proliferation through GPER/GPR30
Chevalier, N., Bouskine, A., & Fénichel, P. (2011) · International Journal of Cancer · doi:10.1002/ijc.25972 · Cited by 91
Signaling via GPR30 protects the myocardium from ischemia/reperfusion injury
Weil, B. R., Manukyan, M. C., Herrmann, J. L., Wang, Y., Abarbanell, A. M., Poynter, J. A., & Meldrum, D. R. (2010) · Surgery · doi:10.1016/j.surg.2010.03.011 · Cited by 83
Rowlands, D. J., Chapple, S. J., Siow, R. C. M., & Mann, G. E. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.162198 · Cited by 83
Extra‐nuclear signaling of estrogen receptors
Fu, X., & Simoncini, T. (2008) · IUBMB Life · doi:10.1002/iub.80 · Cited by 81
Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
Vergote, I. B., & Abram, P. (2005) · Annals of Oncology · doi:10.1093/annonc/mdj047 · Cited by 81
Two Novel GPER Agonists Induce Gene Expression Changes and Growth Effects in Cancer Cells
Lappano, R., Rosano, C., Santolla, M. F., Pupo, M., Francesco, E. M. D., Marco, P. D., Ponassi, M., Spallarossa, A., Ranise, A., & Maggiolini, M. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912800673284 · Cited by 80
Regulation of Vascular Smooth Muscle Tone by Adipose-Derived Contracting Factor
Meyer, M. R., Fredette, N. C., Barton, M., & Prossnitz, E. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079245 · Cited by 79
Self-citationLenhart, P., Broselid, S., Barrick, C. J., Leeb-Lundberg, L. M. F., & Caron, K. M. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0021 · Cited by 78
The novel estrogen receptor G-protein-coupled receptor 30 is expressed in human bone
Heino, T. J., Chagin, A. S., & Savendahl, L. S. (2008) · Journal of Endocrinology · doi:10.1677/joe-07-0629 · Cited by 77
Yates, M. A., Li, Y., Chlebeck, P. J., & Offner, H. (2010) · BMC Immunology · doi:10.1186/1471-2172-11-20 · Cited by 77
GPER regulates endothelin-dependent vascular tone and intracellular calcium
Meyer, M. R., Field, A. S., Kanagy, N. L., Barton, M., & Prossnitz, E. R. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.01.007 · Cited by 75
Self-citationAbdelhamid, R. E., Luo, J., VandeVrede, L. A., Kundu, I., Michalsen, B. T., Litosh, V. A., Schiefer, I. T., Gherezghiher, T. B., Yao, P., Qin, Z., et al. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn100106a · Cited by 74
Brunsing, R. L., Owens, K., & Prossnitz, E. R. (2013) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31828d8e3b · Cited by 72
Self-citationPupo, M., Vivacqua, A., Perrotta, I. D., Pisano, A., Aquila, S., Abonante, S., Gasperi‐Campani, A., Pezzi, V., & Maggiolini, M. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.05.023 · Cited by 72
Regulation of Transcription Factors by Heterotrimeric G Proteins
Ho, M. K. C., Su, Y., Yeung, W. W. S., & Wong, Y. H. (2009) · Current Molecular Pharmacology · doi:10.2174/1874-470210902010019 · Cited by 72
Deletion of G Protein–Coupled Estrogen Receptor Increases Endothelial Vasoconstriction
Meyer, M. R., Amann, K., Field, A. S., Hu, C., Hathaway, H. J., Kanagy, N. L., Walker, M. K., Barton, M., & Prossnitz, E. R. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.184606 · Cited by 71
Self-citationMurata, T., Dietrich, H. H., Xiang, C., & Dacey, R. G. (2013) · Stroke · doi:10.1161/strokeaha.112.678177 · Cited by 70
Cabas, I., Rodenas, M. C., Abellán, E., Meseguer, J., Mulero, V., & Ayala, A. G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301613 · Cited by 68
Prevention and endothelial therapy of coronary artery disease
Barton, M. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.05.005 · Cited by 68
Self-citationRandeva (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000452 · Cited by 68
Holm, A., Baldetorp, B., Olde, B., Leeb-Lundberg, L. M. F., & Nilsson, B. (2011) · Journal of Vascular Research · doi:10.1159/000322578 · Cited by 66
Estrogen destabilizes microtubules through an ion‐conductivity‐independent TRPV1 pathway
Goswami, C., Kuhn, J., Dina, O. A., Fernandez-Ballester, G. J., Levine, J. D., Ferrer-Montiel, A. V., & Hucho, T. B. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07270.x · Cited by 65
Corcoran, J., Nicholson, C., Sweeney, M., Charnock, J. C., Robson, S. C., Westwood, M., & Taggart, M. J. (2013) · Molecular Human Reproduction · doi:10.1093/molehr/gat095 · Cited by 64
Rapid vascular cell responses to estrogen and membrane receptors
Haynes, M. P., Li, L., Russell, K. S., & Bender, J. R. (2002) · Vascular Pharmacology · doi:10.1016/s0306-3623(02)00133-7 · Cited by 63
Sheng, Z.-G., Huang, W., Liu, Y., & Zhu, B. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.12.014 · Cited by 62
Chronic Activation of the G Protein-Coupled Receptor 30 with Agonist G-1 Attenuates Heart Failure
Kang, S., Liu, Y., Sun, D., Zhou, C., Liu, A., Xu, C., Hao, Y., Li, D., Yan, C., & Sun, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048185 · Cited by 59
Recent insights into non-nuclear actions of estrogen receptor alpha
Banerjee, S., Chambliss, K. L., Mineo, C., & Shaul, P. W. (2014) · Steroids · doi:10.1016/j.steroids.2013.11.002 · Cited by 58
Movérare‐Skrtic, S., Börjesson, A., Farman, H. H., Sjögren, K., Windahl, S. H., Lagerquist, M. K., Andersson, A., Stubelius, A., Carlsten, H., Gustafsson, J.-Α., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322910111 · Cited by 57
Lindsey, S. H., da Silva, A. S., Silva, M. S. B., & Chappell, M. C. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00649.2012 · Cited by 57
ER , ER , and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis
Meyer, M. R., & Barton, M. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp187 · Cited by 57
Self-citationZucchetti, A. E., Barosso, I. R., Boaglio, A. C., Basiglio, C. L., Miszczuk, G. S., Larocca, M. C., Ruiz, L. M., Davio, C. A., Roma, M. G., Crocenzi, F. A., et al. (2013) · Hepatology · doi:10.1002/hep.26752 · Cited by 56
Ma, Y., Qiao, X., Falone, A. E., Reslan, O. M., Sheppard, S. J., & Khalil, R. A. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000320569 · Cited by 55
17β-Estradiol Prevents Early-Stage Atherosclerosis in Estrogen Receptor-Alpha Deficient Female Mice
Villablanca, A. C., Tenwolde, A., Lee, M., Huck, M. J., Mumenthaler, S. M., & Rutledge, J. C. (2009) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-009-9103-z · Cited by 54
Ramesh, C., Nayak, T. K., Burai, R., Dennis, M. K., Hathaway, H. J., Sklar, L. A., Prossnitz, E. R., & Arterburn, J. B. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9011802 · Cited by 52
Self-citationHofmeister, M. V., Damkier, H. H., Christensen, B. M., Olde, B., Leeb-Lundberg, L. M. F., Fenton, R. A., Prætorius, H. A., & Prætorius, J. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00343.2011 · Cited by 51
Li, Z.-L., Liu, J., Liu, S., Li, X., Yi, D., & Zhao, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038787 · Cited by 51
Li, F., Yu, X., Szynkarski, C. K., Meng, C., Zhou, B., Barhoumi, R., White, R. E., Heaps, C. L., Stallone, J. N., & Han, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064771 · Cited by 50
Resveratrol inhibits Kv2.2 currents through the estrogen receptor GPR30-mediated PKC pathway
Dong, W., Chen, J.-C., He, Y., Xu, J., & Mei, Y. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00146.2013 · Cited by 49
Li, Y., Birnbaumer, L., & Teng, C. T. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0148 · Cited by 49
Aldosterone increases cardiac vagal tone via G protein‐coupled oestrogen receptor activation
Brailoiu, G. C., Benamar, K., Arterburn, J. B., Gao, E., Rabinowitz, J. E., Koch, W. J., & Brailoiu, E. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.257204 · Cited by 49
2-Methoxyestradiol binding of GPR30 down-regulates angiotensin AT1 receptor
Koganti, S., Snyder, R. O., Gumaste, U., Karamyan, V. T., & Thekkumkara, T. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.10.064 · Cited by 48
Fraser, S. P., Ozerlat‐Gunduz, I., Onkal, R., Diss, J. K. J., Latchman, D. S., & Djamgoz, M. B. A. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22154 · Cited by 47
Reslan, O. M., Yin, Z., do Nascimento, G. R. A., & Khalil, R. A. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31828bc88a · Cited by 47
GPER: A novel target for non-genomic estrogen action in the cardiovascular system
Han, G., Li, F., Yu, X., & White, R. E. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.02.008 · Cited by 47
Splice isoform estrogen receptors as integral transmembrane proteins
Kim, K. H., Toomre, D. K., & Bender, J. R. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-05-0416 · Cited by 44
G protein-coupled estrogen receptor 1-mediated effects in the rat myometrium
Tica, A. A., Dun, E. C., Tica, O. S., Gao, X. Y., Arterburn, J. B., Brailoiu, G. C., Oprea, T. I., & Brailoiu, E. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00501.2010 · Cited by 43
Contributions of Academic Laboratories to the Discovery and Development of Chemical Biology Tools
Huryn, D. M., Resnick, L., & Wipf, P. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400132d · Cited by 40
Chevalier, N., Paul, R., Camparo, P., Michiels, J., Chevallier, D., & Fénichel, P. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15011574 · Cited by 39
Pavlik, R., Wypior, G., Hecht, S., Papadopoulos, P., Kupka, M. S., Thaler, C., Wiest, I., Pestka, A., Friese, K., & Jeschke, U. (2011) · Histochemistry and Cell Biology · doi:10.1007/s00418-011-0846-7 · Cited by 39
Inflammation and Atherosclerosis
Barton, M., Minotti, R., & Haas, E. (2007) · Circulation Research · doi:10.1161/circresaha.107.162487 · Cited by 39
Self-citationLindsey, S. H., & Chappell, M. C. (2011) · Gender Medicine · doi:10.1016/j.genm.2011.10.004 · Cited by 38
ERα-associated protein networks
Schultz-Norton, J. R., Ziegler, Y., & Nardulli, A. M. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.11.005 · Cited by 38
The Genetics of Primary Aldosteronism
Funder, J. W. (2011) · Science · doi:10.1126/science.1202887 · Cited by 37
Li, Y., Chen, Y., Zhu-xia, Z., Liu, X., Yang, L., Wan, L., Lei, T., & Wang, X. (2013) · Toxicology · doi:10.1016/j.tox.2013.04.012 · Cited by 36
Tanrıöver, M. D., Bora, G., Uluturk, T. D., Erden, D. D., Tanrıöver, A., Kılıçarslan, A., Oz, S. G., Erdem‐Yurter, H., Sözen, T., & Guven, G. S. (2010) · Clinical Rheumatology · doi:10.1007/s10067-010-1548-6 · Cited by 34
Liu, L., Zhao, Y., Xie, K., Sun, X., Gao, Y., & Wang, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083072 · Cited by 33
Biochemical mechanisms of cellular catabolism
Tisdale, M. J. (2002) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200207000-00009 · Cited by 32
Volpe, M., Gigante, B., Enea, I., et al. (1997) · Circulation Research · doi:10.1161/01.res.81.5.857 · Cited by 32
Cyclooxygenase isoforms and atherosclerosis
Belton, O., & Fitzgerald, D. J. (2003) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399403005842 · Cited by 31
Cited by
Estrogen receptor signaling mechanisms
(2019) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2019.01.001 · Cited by 988
Estrogen Effects on Cognitive and Synaptic Health Over the Lifecourse
Hara, Y., Waters, E. M., McEwen, B. S., & Morrison, J. H. (2015) · Physiological Reviews · doi:10.1152/physrev.00036.2014 · Cited by 470
Molecular mechanism of estrogen–estrogen receptor signaling
Yaşar, P., Ayaz, G., User, S. D., Güpür, G., & Muyan, M. (2017) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12006 · Cited by 482
Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics
Puré, E., & Blomberg, R. (2018) · Oncogene · doi:10.1038/s41388-018-0275-3 · Cited by 391
Role of estrogen receptors in health and disease
Chen, P., Li, B., & Ou-Yang, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.839005 · Cited by 339
Metadata
- Authors
- Prossnitz, E. R., & Barton, M.
- Venue
- Molecular and Cellular Endocrinology
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 389
- Issue
- 1-2
- Pages
- 71-83
- ISSN
- 0303-7207 (ISSN-L)
- OpenAlex
- W2012644882
- Cited by
- 400
- References
- 219
- FWCI
- 24.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.